retatrutide triple hormone receptor agonist mechanism of action ​"Triple-Hormone" Drug Shows Record Weight Loss: At the American Diabetes Association's 2026 Scientific Sessions, researchers unveiled phase 3 trial results for retatrutide, the first therapy to Incretin & Hormone Receptor Agonists

Each GLP-1 medication has patient-specific dosing

The retatrutide dose schedule tested in clinical settings follows a different escalation pattern than tirzepatide, with wider dose ranges and more complex titration options

For example, in 2023, the European Medicines Agency began investigating over 150 reports of suicidal ideation and other psychiatric symptoms linked to GLP-1 receptor agonists, including Ozempic and Wegovy

Whats new about them is that the companies then realized, Oh my God, they actually work on weight loss. When Ozempic began being used off-label for weight loss, Novo Nordisk also developed Wegovy for weight loss, with Eli Lilly releasing Mounjaro and Trulicity

However, native GLP-1 has low stability in vivo and is inactivated by the enzyme DPP-4 [34].Two strategies exist for overcoming this problem: first, the development of GLP-1 receptor agonists (GLP-1RAs) that activate GLP-1 receptors similarly to native GLP-1

Want to take your transformation even further